Article

The epidemiology of severe Streptococcus pyogenes associated disease in Europe.

Health Protection Agency Centre for Infections, London, United Kingdom.
Euro surveillance: bulletin europeen sur les maladies transmissibles = European communicable disease bulletin (impact factor: 6.15). 10/2005; 10(9):179-84. pp.179-84
Source: PubMed

ABSTRACT Several European countries reported outbreaks of severe disease caused by Streptococcus pyogenes in the late 1980s. This marked a departure from the previous decades, where very few such outbreaks were noted. These changes in disease occurrence formed part of a global phenomenon, the reasons for which have yet to be explained. Results of surveillance activities for invasive S. pyogenes infection within Europe over the past fifteen years identified further increases in many countries. However, variations in surveillance methods between countries preclude robust comparisons being made, illustrating the need for a unified surveillance strategy across Europe. This was finally embodied in the Strep-EURO programme, introduced in 2002.

0 0
 · 
0 Bookmarks
 · 
22 Views
  • Source
    Article: Severe Streptococcus pyogenes infections, United Kingdom, 2003-2004.
    Theresa L Lamagni, Shona Neal, Catherine Keshishian, Neelam Alhaddad, Robert George, Georgia Duckworth, Jaana Vuopio-Varkila, Androulla Efstratiou
    [show abstract] [hide abstract]
    ABSTRACT: As part of a Europe-wide initiative to explore current epidemiologic patterns of severe disease caused by Streptococcus pyogenes, the United Kingdom undertook enhanced population-based surveillance during 2003-2004. A total of 3,775 confirmed cases of severe S. pyogenes infection were identified over 2 years, 3.33/100,000 population, substantially more than previously estimated. Skin/soft tissue infections were the most common manifestation (42%), followed by respiratory tract infections (17%). Injection drug use was identified as a risk factor for 20% of case-patients. One in 5 infected case-patients died within 7 days of diagnosis; the highest mortality rate was for cases of necrotizing fasciitis (34%). Nonsteroidal antiinflammatory drugs, alcoholism, young age, and infection with emm/M3 types were independently associated with increased risk for streptococcal toxic shock syndrome. Understanding the pattern of these diseases and predictors of poor patient outcome will help with identification and assessment of the potential effect of targeted interventions.
    Emerging infectious diseases 03/2008; 14(2):202-9. · 6.17 Impact Factor
  • Source
    Article: Prospective surveillance of invasive group a streptococcal disease, Fiji, 2005-2007.
    Andrew C Steer, Adam Jenney, Joseph Kado, Michael F Good, Michael Batzloff, Lepani Waqatakirewa, E Kim Mullholland, Jonathan R Carapetis
    [show abstract] [hide abstract]
    ABSTRACT: We undertook a prospective active surveillance study of invasive group A streptococcal (GAS) disease in Fiji over a 23-month period, 2005-2007. We identified 64 cases of invasive GAS disease, which represents an average annualized all-ages incidence of 9.9 cases/100,000 population per year (95% confidence interval [CI] 7.6-12.6). Rates were highest in those >65 years of age and in those <5 years, particularly in infants, for whom the incidence was 44.9/100,000 (95% CI 18.1-92.5). The case-fatality rate was 32% and was associated with increasing age and underlying coexisting disease, including diabetes and renal disease. Fifty-five of the GAS isolates underwent emm sequence typing; the types were highly diverse, with 38 different emm subtypes and no particular dominant type. Our data support the view that invasive GAS disease is common in developing countries and deserves increased public health attention.
    Emerging Infectious Diseases 02/2009; 15(2):216-22. · 6.79 Impact Factor
  • Source
    Article: Group A streptococcal cellulitis in the early puerperium.
    Branka Nikolić, Ana Mitrović, Svetlana Dragojević-Dikić, Snezana Rakić, Zlatica Cakić, Milena Saranović, Milan Sikimić
    [show abstract] [hide abstract]
    ABSTRACT: Infectious diseases caused by Streptococcus pyogenes, a member of the group A Streptococci (GAS) are among the most common life threatening ones. Patients with GAS infections have a poor survival rate. Cellulitis is a severe invasive GAS infection and the most common clinical presentation of the disease associated with more deaths than it can be seen in other GAS infections. According to the literature data, most cases of GAS toxic shock syndrome are developed in the puerperium. However, there are two main problems with GAS infection in early puerperium and this case report is aimed at reminding on them. The first problem is an absence of awareness that it can be postpartal invasive GAS infection before the microbiology laboratory confirms it, and the second one is that we have little knowledge about GAS infection, in general. A 32-year-old healthy woman, gravida 1, para 1, was hospitalized three days after vaginal delivery with a 38-hour history of fever, pain in the left leg (under the knee), and head injury after short period of conscious lost. Clinical picture of GAS infection was cellulites. Group A Streptoccocus pyogenes was isolated in vaginal culture. Rapid antibiotic and supportive treatment stopped development of streptococcal toxic shock syndrome (STSS) and potential multiorganic failure. Signs and symptoms of the infection lasted 25 days, and complete recovery of the patient almost 50 days. In all women in childbed with a history of fever early after delivery, vaginal and cervical culture specimens should be taken as soon as possible. Early recognition of GAS infection in early puerperium and prompt initiation of antimicrobial drug and supportive therapy can prevent development of STSS and lethal outcome.
    Vojnosanitetski pregled. Military-medical and pharmaceutical review 07/2011; 68(7):607-10. · 0.18 Impact Factor

Show more

Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.

Keywords

countries
 
countries preclude robust comparisons
 
disease occurrence
 
European countries
 
fifteen years
 
illustrating
 
invasive S. pyogenes infection
 
previous decades
 
reasons
 
severe disease
 
Strep-EURO programme
 
unified surveillance strategy